Support for innovative environment

The Institute of Hematology and Blood Transfusion has established, in cooperation with the Technology Agency of the Czech Republic (TAČR), an internal innovation environment that allows it to implement a complete development cycle for medicinal products of modern and gene therapy.

The innovation cycle is based on the requirements of clinical physicians who, in the care of patients IHBT, encounter interesting clinical problems and formulate assignments to inspire basic research in IHBT.
IHBT has built infrastructure for applied research, which enables successful basic research projects to be implemented in practice – for example, to prepare the production of a new medicinal product or to validate a new diagnostic method.
The results of applied research must be verified in patients in clinical trials. The outputs of clinical trials are then passed back to clinical physicians and can inspire further research development.

TAČR Innovation Projects

In cooperation with the Technology Agency of the Czech Republic, IHBT implements applied research projects of the "proof-of-concept" type, which have invaluable significance for the phase of technology transfer of basic research outputs into therapeutic practice.

During a period 2024-2028, a project from the 4th public call of TAČR SIGMA number TQ11000057 – "Successful commercialization of hematological, hematooncological and immunotherapeutic products II" is being implemented.